SEC Comment Letter 0000000000-24-005788 to BIODESIX INC (BDSX) (CIK 0001439725) (BDSX)
BIODESIX INC (BDSX) (CIK 0001439725)
Date: May 17, 2024 · CIK: 0001439725 · Accession: 0000000000-24-005788
AI Filing Summary & Sentiment
File numbers found in text: 333-278881
Letter
United States securities and exchange commission logo May 17, 2024 Scott Hutton Chief Executive Officer Biodesix, Inc. 919 West Dillon Rd. Louisville, Colorado 80027 Re:Biodesix, Inc. Registration Statement on Form S-1 Filed April 23, 2024 File No. 333-278881 Dear Scott Hutton: We have conducted a limited review of your registration statement and have the following comment. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Form S-1 filed April 23, 2024 General 1.We note your disclosure on page 153 that your selling securityholders may sell their securities through one or more underwritten offerings on a firm commitment or best efforts basis. Please confirm your understanding that the retention by a selling stockholder of an underwriter would constitute a material change to your plan of distribution requiring a post-effective amendment. Refer to your undertaking provided pursuant to Item 512(a)(1)(iii) of Regulation S-K. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration
FirstName LastNameScott Hutton Comapany NameBiodesix, Inc. May 17, 2024 Page 2 FirstName LastName Scott Hutton Biodesix, Inc. May 17, 2024 Page 2 statement. Please contact Jane Park at 202-551-7439 or Lauren Nguyen at 202-551-3642 with any other questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Samir Gandhi, Esq.
Show Raw Text
United States securities and exchange commission logo
May 17, 2024
Scott Hutton
Chief Executive Officer
Biodesix, Inc.
919 West Dillon Rd.
Louisville, Colorado 80027
Re:Biodesix, Inc.
Registration Statement on Form S-1
Filed April 23, 2024
File No. 333-278881
Dear Scott Hutton:
We have conducted a limited review of your registration statement and have the
following comment.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe a comment applies to your facts and circumstances
or do not believe an amendment is appropriate, please tell us why in your response.
After reviewing any amendment to your registration statement and the information you
provide in response to this letter, we may have additional comments.
Form S-1 filed April 23, 2024
General
1.We note your disclosure on page 153 that your selling securityholders may sell their
securities through one or more underwritten offerings on a firm commitment or best
efforts basis. Please confirm your understanding that the retention by a selling stockholder
of an underwriter would constitute a material change to your plan of distribution requiring
a post-effective amendment. Refer to your undertaking provided pursuant to Item
512(a)(1)(iii) of Regulation S-K.
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate
time for us to review any amendment prior to the requested effective date of the registration
FirstName LastNameScott Hutton
Comapany NameBiodesix, Inc.
May 17, 2024 Page 2
FirstName LastName
Scott Hutton
Biodesix, Inc.
May 17, 2024
Page 2
statement.
Please contact Jane Park at 202-551-7439 or Lauren Nguyen at 202-551-3642 with any
other questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Samir Gandhi, Esq.